Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Monica, Mazzucato"'
Autor:
Céline Angin, Monica Mazzucato, Stefanie Weber, Kurt Kirch, Waed Abdel Khalek, Houda Ali, Sylvie Maiella, Annie Olry, Anne-Sophie Jannot, Ana Rath
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-9 (2024)
Abstract Background In European Union countries, any disease affecting less than 5 people in 10,000 is considered rare. As expertise is scarce and rare diseases (RD) are complex, RD patients can remain undiagnosed for many years. The period of search
Externí odkaz:
https://doaj.org/article/8779247dca114d259e89e33baec1d752
Autor:
Monica Mazzucato, Laura Visonà Dalla Pozza, Cinzia Minichiello, Ema Toto, Andrea Vianello, Paola Facchin
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-3 (2024)
Externí odkaz:
https://doaj.org/article/d8f8a0e148b8454a9a8bdb5c0212127c
Autor:
Monica Mazzucato, Laura Visonà Dalla Pozza, Cinzia Minichiello, Ema Toto, Andrea Vianello, Paola Facchin
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-11 (2023)
Abstract Background Rare diseases (RD) are a heterogeneous group of diseases, sharing aspects of complexity. Prognosis is variable, even in individuals with the same disease. Real-world data on RD as a whole are scarce. The aim of this study is to pr
Externí odkaz:
https://doaj.org/article/c36e32bded324fa0b3dd34a489fdd355
Autor:
Monica Mazzucato, Laura Visonà Dalla Pozza, Paola Facchin, Cèline Angin, Francis Agius, Clara Cavero-Carbonell, Virginia Corrochano, Katerina Hanusova, Kurt Kirch, Deborah Lambert, Caterina Lucano, Sylvie Maiella, Monica Panzaru, Cristina Rusu, Stefanie Weber, Oscar Zurriaga, Miroslav Zvolsky, Ana Rath
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-10 (2023)
Abstract Background Estimates of rare disease (RD) population impact in terms of number of affected patients and accurate disease definition is hampered by their under-representation in current coding systems. This study tested the use of a specific
Externí odkaz:
https://doaj.org/article/92bdc030169a4604a94410a63f004f43
Autor:
Monica Mazzucato, Cinzia Minichiello, Andrea Vianello, Laura Visonà dalla Pozza, Ema Toto, Paola Facchin
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Despite calls for the use of real-world data, the rare diseases (RD) treatment landscape suffers from a scarcity of data referred to orphan medicinal products (OMP) use at the population level.Objectives: We aim to describe the characteri
Externí odkaz:
https://doaj.org/article/1fd28792b8eb4cf2a2841f8f328b9091
Autor:
Mariolino De Cecco, Alessandro Luchetti, Isidro Butaslac, Francesco Pilla, Giovanni Maria Achille Guandalini, Jacopo Bonavita, Monica Mazzucato, Kato Hirokazu
Publikováno v:
Information, Vol 14, Iss 4, p 204 (2023)
In rehabilitation settings that exploit Mixed Reality, a clinician risks losing empathy with the patient by being immersed in different worlds, either real and/or virtual. While the patient perceives the rehabilitation stimuli in a mixed real–virtu
Externí odkaz:
https://doaj.org/article/02b9ca095a87488b9faab15b7602d59f
Autor:
Bruno Dallapiccola, Stefano Moriconi, Massimo Rugge, Massimo Cardillo, Carlo Carcassi, Michele Colledan, Luca Dello Strologo, Carlo Dionisi Vici, Paola Facchin, Bruno Gridelli, Valentino La Rocca, Letizia Lombardini, Monica Mazzucato, Daniela Peritore, Antonio Amoroso
Publikováno v:
Clinical Transplantation. 36
Although a disease is defined as rare when it has a prevalence of less than 1:2000, the overall prevalence of rare diseases in the population is greater than 1%. Among potential organ donors, a similar frequency is observed. To date, guidelines have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70c793b86a40106882dbafc8c4735dc6
https://doi.org/10.1111/ctr.14769
https://doi.org/10.1111/ctr.14769
Autor:
Monica, Mazzucato, Cinzia, Minichiello, Laura, Visonà Dalla Pozza, Andrea, Vianello, Ema, Toto, Miriam, De Lorenzi, Giovanna, Scroccaro, Paola, Facchin
Publikováno v:
Recenti progressi in medicina. 113(7)
Rare disease (RD) patients present complex therapeutic needs. When there are therapeutic options available, orphan drugs (OD) represent only a limited proportion of prescribed treatments. This study aims at investigating the real-world use of treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4072a5501b5386fab2a3a388d03a399d
https://pubmed.ncbi.nlm.nih.gov/35852080
https://pubmed.ncbi.nlm.nih.gov/35852080
Autor:
Silvia Manea, Laura Visonà Dalla Pozza, Cinzia Minichiello, Linda Altieri, Monica Mazzucato, Mauro Bonin, Paola De Ambrosis, Elio Borgonovi, Paola Facchin
Publikováno v:
Health Services Management Research. :095148482311518
Background: in the field of rare diseases (RDs) most of the European studies on budget impact analysis of drugs that have been conducted often lay on theoretical assumptions and focus only on Orphan drugs (ODs). Objectives: we aimed to estimate the b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d8c58f9b38aec4759f97c32b51bed79
https://doi.org/10.1177/09514848231151814
https://doi.org/10.1177/09514848231151814
Autor:
Raffaella Colombatti, Laura Visonà Dalla Pozza, Monica Mazzucato, Laura Sainati, Marta Pierobon, Paola Facchin
Publikováno v:
Haematologica, Vol 93, Iss 3 (2008)
Sickle cell disease (SCD) has become a paradigm of immigration hematology in Europe. Accurate up-to date information is needed to determine SCD prevalence, define real burden of disease and develop appropriate clinical networks of care, especially in
Externí odkaz:
https://doaj.org/article/e1f4cef94d7b4001bb1ba4daf2b6f721